136 related articles for article (PubMed ID: 37314860)
1. Optic Neuritis After COVID-19 Vaccination: An Analysis of the Vaccine Adverse Event Reporting System.
Jaffry M; Aftab OM; Mostafa FB; Faiz I; Jaffry K; Mandava K; Rosario S; Jedidi K; Khan H; Souayah N
J Neuroophthalmol; 2023 Dec; 43(4):499-503. PubMed ID: 37314860
[TBL] [Abstract][Full Text] [Related]
2. No significant increase in Guillain-Barré syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study.
Jaffry M; Mostafa F; Mandava K; Rosario S; Jagarlamudi Y; Jaffry K; Kornitzer J; Jedidi K; Khan H; Souayah N
Vaccine; 2022 Sep; 40(40):5791-5797. PubMed ID: 36055875
[TBL] [Abstract][Full Text] [Related]
3. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
4. Reporting rates for VAERS death reports following COVID-19 vaccination, December 14, 2020-November 17, 2021.
Day B; Menschik D; Thompson D; Jankosky C; Su J; Moro P; Zinderman C; Welsh K; Dimova RB; Nair N
Pharmacoepidemiol Drug Saf; 2023 Jul; 32(7):763-772. PubMed ID: 36813704
[TBL] [Abstract][Full Text] [Related]
5. Otorhinolaryngologic complications after COVID-19 vaccination, vaccine adverse event reporting system (VAERS).
Shin J; Shim SR; Lee J; Ryu HS; Kim JY
Front Public Health; 2023; 11():1338862. PubMed ID: 38269374
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
Front Immunol; 2021; 12():669010. PubMed ID: 34093567
[TBL] [Abstract][Full Text] [Related]
7. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe.
Rosenblum HG; Gee J; Liu R; Marquez PL; Zhang B; Strid P; Abara WE; McNeil MM; Myers TR; Hause AM; Su JR; Markowitz LE; Shimabukuro TT; Shay DK
Lancet Infect Dis; 2022 Jun; 22(6):802-812. PubMed ID: 35271805
[TBL] [Abstract][Full Text] [Related]
8. Herpetic Eye Disease After SARS-CoV-2 Vaccination: A CDC-VAERS Database Analysis.
Singh RB; Parmar UPS; Ichhpujani P; Jeng BH; Jhanji V
Cornea; 2023 Jun; 42(6):731-738. PubMed ID: 36706232
[TBL] [Abstract][Full Text] [Related]
9. Case-centered Analysis of Optic Neuritis After Vaccines.
Baxter R; Lewis E; Fireman B; DeStefano F; Gee J; Klein NP
Clin Infect Dis; 2016 Jul; 63(1):79-81. PubMed ID: 27069066
[TBL] [Abstract][Full Text] [Related]
10. Post-vaccination headache reporting: Trends according to the Vaccine Adverse Events Reporting System.
Cocores AN; Goadsby PJ; Monteith TS
Headache; 2023 Feb; 63(2):275-282. PubMed ID: 36651626
[TBL] [Abstract][Full Text] [Related]
11. Optic Neuritis After SARS-CoV-2 Vaccination.
Shemer A; Greenbaum A; Toledano A; Biron R; Dubinsky-Pertzov B; Or L
J Neuroophthalmol; 2023 Mar; 43(1):29-33. PubMed ID: 36790061
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS).
Zhang B; Yu X; Liu J; Liu J; Liu P
BMC Womens Health; 2022 Oct; 22(1):403. PubMed ID: 36195902
[TBL] [Abstract][Full Text] [Related]
13. Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on.
Mangat HS; Musah A; Luedtke S; Syed AA; Maramattom BV; Maruthanal J; Bosman A; Kostkova P
Front Public Health; 2022; 10():972464. PubMed ID: 36311588
[TBL] [Abstract][Full Text] [Related]
14. Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD).
Niu MT; Rhodes P; Salive M; Lively T; Davis DM; Black S; Shinefield H; Chen RT; Ellenberg SS
J Clin Epidemiol; 1998 Jun; 51(6):503-10. PubMed ID: 9635999
[TBL] [Abstract][Full Text] [Related]
15. Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021.
See I; Lale A; Marquez P; Streiff MB; Wheeler AP; Tepper NK; Woo EJ; Broder KR; Edwards KM; Gallego R; Geller AI; Jackson KA; Sharma S; Talaat KR; Walter EB; Akpan IJ; Ortel TL; Urrutia VC; Walker SC; Yui JC; Shimabukuro TT; Mba-Jonas A; Su JR; Shay DK
Ann Intern Med; 2022 Apr; 175(4):513-522. PubMed ID: 35038274
[TBL] [Abstract][Full Text] [Related]
16. Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data.
Li Y; Lundin SK; Li J; Tao W; Dang Y; Chen Y; Tao C
Expert Rev Vaccines; 2024; 23(1):53-59. PubMed ID: 38063069
[TBL] [Abstract][Full Text] [Related]
17. Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021-February 2022.
Woo EJ; Gee J; Marquez P; Baggs J; Abara WE; McNeil MM; Dimova RB; Su JR
Vaccine; 2023 Jul; 41(30):4422-4430. PubMed ID: 37321898
[TBL] [Abstract][Full Text] [Related]
18. Hearing disorder following COVID-19 vaccination: A pharmacovigilance analysis using the Vaccine Adverse Event Reporting System.
Chen C; Fu F; Ding L; Xiao J
J Clin Pharm Ther; 2022 Nov; 47(11):1789-1795. PubMed ID: 36089844
[TBL] [Abstract][Full Text] [Related]
19. Vaccine-Associated Uveitis after COVID-19 Vaccination: Vaccine Adverse Event Reporting System Database Analysis.
Singh RB; Parmar UPS; Kahale F; Agarwal A; Tsui E
Ophthalmology; 2023 Feb; 130(2):179-186. PubMed ID: 36055601
[TBL] [Abstract][Full Text] [Related]
20. Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States.
Abara WE; Gee J; Marquez P; Woo J; Myers TR; DeSantis A; Baumblatt JAG; Woo EJ; Thompson D; Nair N; Su JR; Shimabukuro TT; Shay DK
JAMA Netw Open; 2023 Feb; 6(2):e2253845. PubMed ID: 36723942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
